Skip to content

Early diagnosis and monitoring of ultrasound imaging for breast cancer chemotherapy -related peripheral neuropathy

Early diagnosis and monitoring of ultrasound imaging for breast cancer chemotherapy -related peripheral neuropathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091527
Enrollment
Unknown
Registered
2024-10-30
Start date
2024-10-31
Completion date
Unknown
Last updated
2024-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer chemotherapy -related peripheral neuropathy

Interventions

Non chemotherapy group/ Chemotherapy group:None

Sponsors

Zhuhai People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients who are diagnosed with breast cancer and without any treatment; 2.age is over 18 years old; 3.agreed to participate in research;

Exclusion criteria

Exclusion criteria: 1.There are other known neuropathy or neurological diseases, such as chronic inflammatory desertic deinellic multi-neuropathy (CIDP), Jilan Baror syndrome, etc. 2.There are other factors that cause peripheral neuropathy, such as diabetes, nutritional metabolism Obstacles, alcoholism, autoimmune diseases, hereditary diseases, etc. 3.Have severe heart disease or kidney disease; 4.pregnant or lactating women; 5.Patients with contraindications to ultrasound examination;

Design outcomes

Primary

MeasureTime frame
Ultrasonic measuring peripheral nerves (including the center nerve, ulnar nerve, radial nerve, tibial nerve, and gastrocity nerve) of the cross sectional section, circumference, width, and thickness.;

Countries

China

Contacts

Public ContactYang Yi

Zhuhai People's Hospital

1876287271@qq.com+86 756 2157828

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026